1,721,498 research outputs found
Drug-receptor binding kinetics in drug discovery: Sticking around at the histamine H1 receptor
Leurs, R. [Promotor]Vischer, H.F. [Copromotor
Pharmacological Characterization of Novel Histamine H4 Receptor Ligands
Leurs, R. [Promotor]Vischer, H.F. [Copromotor
Exploring the Chemokine Receptor CXCR2: Ligand Recognition and Response
Leurs, R. [Promotor]Smit, M.J. [Promotor
Dimerization and signaling of the chemokine receptors CXCR3 and CCX-CKR
Leurs, R. [Promotor]Vischer, H.F. [Copromotor
Trypanosoma brucei phosphodiesterase B1 as a drug target for Human African Trypanosomiasis
Leurs, R. [Promotor]Esch, I.J.P. de [Promotor
Design and Synthesis of New Histamine H4 Receptor Ligands
Leurs, R. [Promotor]Esch, I.J.P. de [Copromotor
Molecular aspects of the histamine H1 receptor
Leurs, R. [Promotor]Bakker, R.A. [Copromotor
Going Beyond Counting First Authors in Author Co-citation Analysis
The present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation
counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings
are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that
only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into
account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed
Chemokine Receptors CXCR3 and CXCR7: Allosteric Ligand Binding, Biased Signaling, and Receptor Regulation
Leurs, R. [Promotor]Smit, M.J. [Promotor
- …
